Admission Date:  [**2131-5-6**]     Discharge Date:  [**2131-9-6**]  Date of Birth:   [**2131-5-6**]     Sex:  M  Service:  Neonatology HISTORY OF PRESENT ILLNESS:  [**Known lastname 43368**] [**Known lastname **] was born at 24-3/7 weeks gestation by spontaneous vaginal delivery to a 29-year-old gravida 1, para 0 (now 1) mother.
Her prenatal screens were blood type B positive, antibody negative, Rubella immune, rapid plasma reagin nonreactive, hepatitis B surface antigen negative, and group beta strep status unknown.
He weaned successfully to nasopharyngeal continuous positive airway pressure on day of life 57, and then weaned to nasal cannula oxygen on day of life 61, and then finally to room air on day of life 110.
He was treated with caffeine for apnea of prematurity from day of life 2 until day of life 64.
He was treated with Diuril for chronic lung disease from day of life 25 to the present time.
He had a left thoracotomy tube placed in the operating room at the time of his posterior descending artery ligation that was removed on postoperative day one.
He completed a course of antibiotics on [**2131-5-22**] for Escherichia coli pneumonia.
CARDIOVASCULAR:  [**Known lastname 43368**] required dopamine for blood pressure support soon after admission to the Neonatal Intensive Care Unit until day of life two.
He was treated with indomethacin on day of life five for clinical presentation of a patent ductus arteriosis with resolution of his symptoms.
FLUIDS/ELECTROLYTES/NUTRITION:  Enteral feeds were given on day of life 15 and advanced to full volume feedings by day of life 30.
He has been taking all oral feedings since [**7-31**].
He is receiving supplemental potassium chloride in conjunction with his Diuril.
He is currently taking feedings of Enfamil concentrated to 24 calories by concentration on an ad lib demand schedule.
GASTROINTESTINAL:  [**Known lastname 43368**] was treated with phototherapy for hyperbilirubinemia from day of life 1 until day of life 22.
[**Known lastname 43368**] is status post right inguinal hernia repair at [**Hospital3 1810**] on [**8-29**].
HEMATOLOGY:  [**Known lastname 43368**] has received a total of five transfusions of packed red blood cells during his Neonatal Intensive Care Unit course.
He is receiving iron supplementation.
INFECTIOUS DISEASE:  The infant was started on ampicillin and gentamicin at the time of admission for sepsis risk factors.
The antibiotics were discontinued after 48 hours, and the blood cultures were negative.
He did complete seven days of gentamicin and ceftazidime for Escherichia coli pneumonia.
On day of life 19, he again had a clinical decompensation and was started on vancomycin and gentamicin.
Blood cultures at that time were positive for group alpha strep, and so he completed seven days of ampicillin treatment for that.
He remained off antibiotics until day of life 45, when a clinical presentation of sepsis and was started on vancomycin and gentamicin.
At that time, his tracheal culture was positive for Escherichia coli, and he completed seven days of antibiotic treatment for that.
He was started on vancomycin and gentamicin at that time and received a 48-hour course.
NEUROLOGY:  [**Known lastname 43368**] has had six ultrasounds during his stay in the Newborn Intensive Care Unit.
OPHTHALMOLOGY:  [**Known lastname 43368**] is status post laser treatment in both eyes for threshold retinopathy of prematurity.
Feeds at discharge:  Ad lib demand feeds of 24-calorie Enfamil.
Medications:  Iron supplements of 0.3 cc q.d., Diuril 60 mg p.o.
b.i.d., and potassium chloride supplements 3 mEq p.o.
IMMUNIZATIONS RECEIVED:  [**Known lastname 43368**] received his first hepatitis B vaccine on [**7-6**] along with his other 2-month immunizations including his DTaP, his hemophilus influenza B, his IPV, and his Prevnar.
He received his second hepatitis B vaccine on [**8-14**].
His received his first dose of Synagis on [**9-6**].
IMMUNIZATIONS RECOMMENDED:  Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  (1) Born at less than 32 weeks.
Influenza immunization should be considered annually in the Fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age, the family and other care givers should be considered for immunization against influenza to protect the infant.
Patent ductus arteriosis; status post ligation on [**2131-5-18**].
Right inguinal hernia; status post repair on [**8-29**].
Retinopathy of prematurity; status post laser therapy.
